can semaglutide cause hypotension GLP-1 drugs tied to blood pressure risks in certain patients, study finds POTD: Wegovy and Ozempic —

Expected weight loss: Minimal (01 kg) 0.5 mg Weeks 58 First therapeutic dose

For patients taking antihypertensive medications, dose adjustments may be necessary as weight loss progresses and blood pressure naturally declines

Use: To reduce the risk of sustained estimated eGFR decline, ESRD, and CV death in patients with type 2 diabetes mellitus and chronic kidney disease Usual Adult Dose for Metabolic Dysfunction-Associated Steatohepatitis Wegovy injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week If 2.4 mg is not tolerated: 1.7 mg subcutaneously once a week

If less than 2 days away, skip the dose and resume your regular schedule